Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2015

View Archived Issues

Study of GABA-A receptor signaling in Down syndrome model yields potential treatment strategy

TaiGen initiates phase I/II trial of burixafor in AML

Discovery of a bacterial RNR-targeting antibiotic to combat resistance

Lycera enters clinic with first program, LYC-30937 for IBD

Advanced Proteome Therapeutics reports findings on APC-191 in tumor metastasis

Tamir Biotechnology updates development progress of TMR-004 for Ebola

Novo Nordisk presents pipeline events of first quarter 2015

AstraZeneca discloses novel PI3Kalpha/delta inhibitior

BioLineRx's phase II study of BL-8040 for AML enters expansion stage

Shire and Foundation Fighting Blindness collaborate on autosomal dominant retinitis pigmentosa

New efficacy data presented for the antibody-drug conjugate ASN-004

Isis licenses ISIS-FXIRx to Bayer for prevention of thrombosis

Eisai develops new TLR7 and TLR8 antagonists

GlaxoSmithKline patents PERK inhibitors

Dana-Farber Cancer Institute discloses CDK7 inhibitors

Syros Pharmaceuticals and Paraza Pharma patent CDK7 inhibitors

The Blanchette Rockefeller Neurosciences Institute patents PKC-epsilon activators

Generon's F-652 cleared to enter phase II for acute graft-versus-host disease

Baxter submits European MAA for MM-398 for pancreatic cancer

European orphan drug designation for Makindus' MI-100 in Stargardt's disease

Dosing begins in Nigerian bridging study of Lodonal for HIV/AIDS

New phase II trial investigates Luminate for non-proliferative diabetic retinopathy

AEOL-10150 doubles survival in primate model of radiation-induced lung injury

CytRx offers interim reports from phase Ib aldoxorubicin combination studies

ARVO news: First-in-human clinical study of RetinoStat in wet AMD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...